ARCHIVES

NCI Reportedly Gets $691 Million From House, Senate Conferees

This article is from The Cancer Letter archive.

Vol. 01 No. 35 | October 4, 1974

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI

February 6, 1976

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Cigarette Smoking increases Among Youth, Annual Report Finds

January 12, 1996

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

November 5, 1999

ASCO Honors Eight With Special Awards

May 24, 2002